Candel therapeutics to present at upcoming investor conferences

Needham, mass., may 06, 2025 (globe newswire) -- candel therapeutics, inc. (candel or the company) (nasdaq: cadl), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, announced today that management will present and participate in one-on-one meetings with investors at upcoming investor conferences.
CADL Ratings Summary
CADL Quant Ranking